Immune Dysregulation: What is it, and what is it NOT?

Date:
Nov 2, 2020 from 8:30 a.m. - 9:30 a.m. (ET)

Overview: Immune dysregulation describes a heterogeneous group of conditions and symptoms that make it hard to recognize. This often delays diagnosis and therapy, as patients without true Immune Dysregulation are sent for evaluation that they don’t need, and patients with Immune Dysregulation often go unrecognized.  This session will provide up to date information on what constitutes Immune Dysregulation, how to recognize Immune Dysregulation in patients, and how to recognize Immune Dysregulation mimickers that are better served by other services.  History, physical exam findings, and laboratory diagnostics will be reviewed as screening tools for Immune Dysregulation.

Speaker: Ed Behrens, MD

Learning Objectives:
Upon completion of this lecture, participants should be able to:

  1. Recognize how to recognize the most common signs and symptoms of Immune Dysregulation.
  2. Recognize the symptoms that commonly mimic Immune Dysregulation.
  3. Determine when a referral to an Immune Dysregulation specialist is appropriate.

Agenda:
8:15-8:30 a.m: Participant log-on
8:30-8:35 a.m: Welcome and Introduction, Dr. Ed Behrens
8:35-9:15 a.m: Presentation of Immune Dysregulation signs, symptoms and mimicking symptoms, Dr. Ed Behrens
9:15-9:30 a.m: Q&A and Wrap-up

Contact: Shelly Norbury, (856) 397-5588, norburys@chop.edu

Register Today

ACCME Accreditation Statement: Children’s Hospital of Philadelphia is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

AMA Credit Designation Statement: Children's Hospital of Philadelphia designates this live activity for a maximum of 1.00 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Disclosure Statement: Ed Behrens, MD, Katie Lockwood, MD (CHOP Talks Course Director) and Monica S. Williams (CME Planner) and others as appropriate have no relevant financial relationship with a commercial interest to disclose

Note: This session will be recorded and made available on our website. If you would like to ask a question during the event but would like to remain anonymous, please do not use your real name when signing in.